T1	Procedure 62 80	neonatal screening
T2	Procedure-Name 62 80	neonatal screening
E1	Procedure:T1 Name:T2
T3	Observation 99 115	Phenylalaninemia
T4	Observation-Name 99 115	Phenylalaninemia
E3	Observation:T3 Name:T4 Eq-Comparison:E20
T5	Condition 974 989	Phenylketonuria
T6	Condition-Name 974 989	Phenylketonuria
E5	Condition:T5 Name:T6
T7	Condition 853 872	pre-conception diet
T8	Condition-Name 853 872	pre-conception diet
E7	Condition:T7 Name:T8
T9	Condition 818 827	Pregnancy
T10	Condition-Name 818 827	Pregnancy
E9	Condition:T9 Name:T10 Temporality:E22
T11	Condition 874 883	pregnancy
T12	Condition-Name 874 883	pregnancy
E11	Condition:T11 Name:T12
T17	Condition 337 340	PKU
T18	Condition-Name 337 340	PKU
E17	Condition:T17 Name:T18
T21	Eq-Operator 116 117	≥
A1	Eq-Operator-Value T21 GTEQ
T22	Eq-Operator 203 204	≥
A2	Eq-Operator-Value T22 GTEQ
T24	Eq-Temporal-Unit 661 665	days
A4	Eq-Temporal-Unit-Value T24 day
T25	Eq-Temporal-Unit 714 720	months
A5	Eq-Temporal-Unit-Value T25 month
T26	Eq-Temporal-Unit 806 812	months
A6	Eq-Temporal-Unit-Value T26 month
T27	Eq-Temporal-Unit 845 851	months
A7	Eq-Temporal-Unit-Value T27 month
T28	Eq-Value 118 121	900
T29	Eq-Value 204 207	900
T30	Eq-Value 659 660	7
T31	Eq-Value 712 713	6
T32	Eq-Value 804 805	6
T33	Eq-Value 843 844	6
T34	Eq-Comparison 116 129	≥ 900μmol / L
E20	Eq-Comparison:T34 Operator:T21 Value:T28 Unit:T39 Unit2:T40
T35	Eq-Comparison 203 216	≥900 μmol / L
E21	Eq-Comparison:T35 Operator:T22 Value:T29 Unit:T45 Per:T46
T36	Eq-Comparison 836 851	within 6 months
E22	Eq-Comparison:T36 Temporal-Unit:T27 Value:T33 Temporal-Period:T23
T37	Condition 25 40	Phenylketonuric
E2	Condition:T37 Name:T38
T38	Condition-Name 25 40	Phenylketonuric
R1	Found-By Arg1:E2 Arg2:E1	
T39	Eq-Unit 121 125	μmol
T40	Eq-Unit 128 129	L
T41	Study 157 166	screening
E4	Study:T41 
T42	Temporal-Connection 146 152	during
E6	Temporal-Connection:T42 Arg:E3 Arg2:E4
A8	Temporal-Connection-Type-Value E6 during
T43	Coreference 186 202	blotting results
E8	Coreference:T43 Refers-To:E3
T44	Observation 186 202	blotting results
E10	Observation:T44 Eq-Comparison:E21 Minimum-Count:E16
T45	Eq-Unit 208 212	μmol
T46	Eq-Unit 215 216	L
T47	Study 250 259	screening
E12	Study:T47 
T48	Temporal-Connection 239 245	during
E14	Temporal-Connection:T48 Arg:E10 Arg2:E12
A9	Temporal-Connection-Type-Value E14 during
T49	Eq-Comparison 220 227	several
E16	Eq-Comparison:T49 Operator:T50
T50	Eq-Operator 220 227	several
A10	Eq-Operator-Value T50 GT
T51	Or 175 177	or
E18	Or:T51 Arg:E3 Arg2:E10
T52	Drug 307 328	amino acid supplement
E23	Drug:T52 Name:T53 Temporality:E25
T53	Drug-Name 307 328	amino acid supplement
T54	Negation 292 295	not
E24	Negation:T54 Negates:E23
T55	Eq-Comparison 296 302	taking
E25	Eq-Comparison:T55 Temporal-Period:T56
T56	Eq-Temporal-Period 296 302	taking
A11	Eq-Temporal-Period-Value T56 present
R2	Treatment-For Arg1:E23 Arg2:E17	
T13	Condition 405 415	court bail
E13	Condition:T13 Name:T14
T14	Condition-Name 405 415	court bail
T57	Condition 417 428	curatorship
E26	Condition:T57 Name:T58
T58	Condition-Name 417 428	curatorship
T59	Condition 430 442	guardianship
E27	Condition:T59 Name:T60
T60	Condition-Name 430 442	guardianship
T61	Condition 461 481	concomitant diseases
E28	Condition:T61 Name:T62
T62	Condition-Name 461 481	concomitant diseases
T63	Condition 484 494	conditions
E29	Condition:T63 
T64	Or 482 483	/
E30	Or:T64 Arg:E28 Arg2:E29
T65	Study 519 524	study
E31	Study:T65 Stability:T66
T66	Stability 504 514	compromise
A12	Stability-Value T66 change
T67	Assertion 500 503	may
E32	Assertion:T67 Asserted:T66
A13	Assertion-Type-Value E32 possible
R3	Caused-By Arg1:T66 Arg2:E29	
T68	Study 587 601	clinical trial
E33	Study:T68 
T69	Study 605 610	trial
E34	Study:T69 Study-Of:E19
T19	Condition 623 626	PKU
E19	Condition:T19 Name:T20
T20	Condition-Name 623 626	PKU
T70	Procedure 636 646	treatments
E35	Procedure:T70 Temporality:E36
T71	Eq-Comparison 654 665	last 7 days
E36	Eq-Comparison:T71 Temporal-Unit:T24 Temporal-Period:T72 Value:T30
T72	Eq-Temporal-Period 654 658	last
A14	Eq-Temporal-Period-Value T72 past
R4	Treatment-For Arg1:E35 Arg2:E19	
T73	Or 602 604	or
E37	Or:T73 Arg:E33 Arg2:E34
T74	Or 633 635	or
E38	Or:T74 Arg:E19 Arg2:E35
T75	Study 675 684	inclusion
E39	Study:T75 
T76	Temporal-Connection 666 671	prior
E40	Temporal-Connection:T76 Arg:E36 Arg2:E39
A15	Temporal-Connection-Type-Value E40 before
T77	Eq-Comparison 707 720	next 6 months
E41	Eq-Comparison:T77 Temporal-Unit:T25 Temporal-Period:T78 Value:T31
T78	Eq-Temporal-Period 707 711	next
A16	Eq-Temporal-Period-Value T78 future
T79	Eq-Comparison 688 695	planned
E42	Eq-Comparison:T79 Temporal-Period:T80
T80	Eq-Temporal-Period 688 695	planned
A17	Eq-Temporal-Period-Value T80 future
T81	Temporal-Connection 696 702	during
E43	Temporal-Connection:T81 Arg:E42 Arg2:E41
A18	Temporal-Connection-Type-Value E43 during
T82	Or 685 687	or
E44	Or:T82 Arg:E39 Arg2:E42
T83	Study 761 766	study
E45	Study:T83 Study-Of:E46
T84	Drug 772 787	health products
E46	Drug:T84 
T85	Eq-Comparison 799 812	next 6 months
E47	Eq-Comparison:T85 Temporal-Unit:T26 Temporal-Period:T86 Value:T32
T86	Eq-Temporal-Period 799 803	next
A19	Eq-Temporal-Period-Value T86 future
T87	Temporal-Connection 788 794	during
E48	Temporal-Connection:T87 Arg:E45 Arg2:E47
A20	Temporal-Connection-Type-Value E48 during
T23	Eq-Temporal-Period 836 842	within
A3	Eq-Temporal-Period-Value T23 past
T15	Condition 887 900	breastfeeding
E15	Condition:T15 Name:T16
T16	Condition-Name 887 900	breastfeeding
T88	Or 884 886	or
E49	Or:T88 Arg:E11 Arg2:E15
T89	Drug 1016 1019	BH4
E50	Drug:T89 Name:T90
T90	Drug-Name 1016 1019	BH4
T91	Procedure 1001 1010	treatment
E51	Procedure:T91 Temporality:E52
R5	Using Arg1:E51 Arg2:E50	
T92	Eq-Comparison 990 1000	undergoing
E52	Eq-Comparison:T92 Temporal-Period:T93
T93	Eq-Temporal-Period 990 1000	undergoing
A21	Eq-Temporal-Period-Value T93 present
R6	Treatment-For Arg1:E51 Arg2:E5	
T94	Study 1054 1059	study
E53	Study:T94 Study-Of:E54
T95	Drug 1040 1047	product
E54	Drug:T95 
T96	Allergy 1025 1032	Allergy
E55	Allergy:T96 Name:E54
